0001415889-23-004600.txt : 20230309 0001415889-23-004600.hdr.sgml : 20230309 20230309170425 ACCESSION NUMBER: 0001415889-23-004600 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230307 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Torley Helen CENTRAL INDEX KEY: 0001528185 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32335 FILM NUMBER: 23720559 MAIL ADDRESS: STREET 1: C/O ONYX PHARMACEUTICALS, INC. STREET 2: 249 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001159036 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 880488686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 794-8889 MAIL ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC DATE OF NAME CHANGE: 20040312 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC DATE OF NAME CHANGE: 20010912 4 1 form4-03092023_100317.xml X0306 4 2023-03-07 0001159036 HALOZYME THERAPEUTICS, INC. HALO 0001528185 Torley Helen C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130 true true false false PRESIDENT AND CEO Common Stock 2023-03-07 4 M 0 10000 14.66 A 633666 D Common Stock 2023-03-07 4 S 0 10000 45.469 D 623666 D Common Stock 2023-03-08 4 M 0 10000 14.66 A 633666 D Common Stock 2023-03-08 4 S 0 10000 43.259 D 623666 D Common Stock 2023-03-09 4 M 0 10000 14.66 A 633666 D Common Stock 2023-03-09 4 S 0 10000 42.727 D 623666 D Option to Purchase Common Stock 14.66 2023-03-07 4 M 0 10000 14.66 D 2024-01-06 Common Stock 10000 20000 D Option to Purchase Common Stock 14.66 2023-03-08 4 M 0 10000 14.66 D 2024-01-06 Common Stock 10000 10000 D Option to Purchase Common Stock 14.66 2023-03-09 4 M 0 10000 14.66 D 2024-01-06 Common Stock 0 0 D The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1. Represents a weighted average sales price per share. The shares were sold at prices ranging from $45.195 to $45.925. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. The shares were sold at prices ranging from $42.74 to $43.625. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. The shares were sold at prices ranging from $42.495 to $43.03. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was January 6, 2014. /s/ James R. Oehler, Attorney-in-Fact 2023-03-09